Diapin Therapeutics is a pre-seed, preclinical development-staged company
Business Model:
Revenue: $0
Employees: 0-0
Address:
City: Ann Arbor
State: MI
Zip: 48109
Country: US
Diapin Therapeutics is a pre-seed, preclinical development-staged company that was founded to develop a three amino acid peptide for the treatment of Type 2 diabetes. Diapin Therapeutics&s; laboratory and office space are located in the University of Michigan Venture Accelerator in Ann Arbor, Michigan. The company was founded in July of 2011 and the technology was spun off from the University of Michigan in June of 2012.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|